ESC 365 - COPS Trial - Colchicine to Improve Cardiovascular Outcomes in ACS Patients

ESC Premium Access

COPS Trial - Colchicine to Improve Cardiovascular Outcomes in ACS Patients

Session: Impact of Colchicine on Cardiovascular Disease

Topic: Pharmacotherapy

Speaker: Doctor J. Layland (Melbourne, AU)

Event: ESC Congress 2020

Congress Presentation

About the speaker

Doctor Jamie Layland

Peninsula Health, Melbourne (Australia)

1 presentation

0 follower

3 more presentations in this session

Online Session - Impact of Colchicine on Cardiovascular Disease - Host and discussant

Speaker: Professor M. Imazio (Turin, IT)

COLCOT Pharmacogenomics

Speaker: Professor M. Dube (Montreal, CA)

Impact of time-to-treatment initiation of colchicine on cardiovascular outcomes after myocardial infarction: insights from the Colchicine Cardiovascular Outcomes Trial (COLCOT)

Speaker: Doctor N. Bouabdallaoui (Montreal, CA)

Access the full session

Impact of Colchicine on Cardiovascular Disease

Speakers: Doctor J. Layland, Professor M. Imazio, Professor M. Dube, Doctor N. Bouabdallaoui

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

Related content

Open Access

Timing and indication of intervention in asymptomatic patients with valvular heart disease.

28 August 2021

ESC Premium Access

Beyond the ISCHEMIA paradigm: updating the role of stress tests, coronary CT and optimisation of medical therapy.

27 August 2021

ESC Premium Access

Colchicine in Acute Myocardial Infarction

27 August 2021

ESC 365 is supported by